SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending as Michael Burry posted old emails with RC and RK, sparking speculation about his continued involvement before earnings. The community is analyzing the timing of Burry's posts and debating potential implications. Some traders are pointing to technical indicators, while others remain skeptical about a potential squeeze.

Joe Coin

JoeCoin is trending as traders discuss its chart patterns, highlighting signs of accumulation and a potential bullish reversal. Community members are pointing to recent IP acquisition news and the establishment of new support levels as possible catalysts. Sentiment suggests conviction among holders despite broader market volatility.

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

SLV is trending as the price of silver approaches all-time highs, fueled by expectations of future rate cuts and a potential supply squeeze. Community members are discussing potential breakouts and long-term price targets, with many pointing to silver's industrial demand and role as an inflation hedge. Some are also noting potential short squeezes and the influence of large market participants.

SPDR Gold Trust - SPDR Gold Shares ETF

SPDR Gold Shares ETF

GLD is trending amid discussions of potential Federal Reserve rate cuts and its role as a safe haven asset during market volatility. Community members are analyzing wedge pattern breakouts and speculating on future price movements, while also considering its performance relative to Bitcoin and the broader market. Broader commentary includes discussions of global debt, economic conditions, and potential for significant moves in precious metals.

Greenwave Technology Solutions, Inc. is an emerging growth company, which engages in recycling ferrous metal. It also recycles nonferrous metals including aluminum, copper, stainless steel, nickel, brass, titanium, lead, alloys, and mixed metal products. The company was founded on April 26, 2013 and is headquartered in Chesapeake, VA.

Greenwave Technology Solutions Inc

GWAV is trending amid discussions of high short interest and potential for a squeeze, though some traders express concern about the company's financials and history of dilution. The community is actively debating the stock's volatile price action and speculating on possible catalysts or further declines. Some are drawing comparisons to other high-flying stocks, while others are pointing to potential delisting risks.

General Dynamics Corp. is a global aerospace and defense company, which engages in design, engineering, and manufacturing to deliver solutions. It operates through the following business segments: Aerospace, Marine Systems, Combat Systems, and Technologies. The Aerospace segment includes the production of business jets, technology aircraft, repair, support and completion services. The Marine Systems segment involves the design and building of nuclear-powered submarines, surface combatant, and auxiliary ship design and construction. The Combat Systems segment focuses on manufacturing and integrating land combat solutions, wheeled and tracked combat vehicles, weapons systems and munitions. The Technologies segment consists of services, technologies, and products for electronic hardware with its software. The company was founded on February 21, 1952 and is headquartered in Reston, VA.

General Dynamics Corp.

General Dynamics ($GD) is trending as traders are actively discussing potential options strategies and upside following recent defense contract news and analyst target price increases. The community is also weighing the stock's technical indicators and potential impacts from geopolitical events. Some see long-term value due to its backlog and position in the defense sector, while others are cautious about potential defense spending cuts.

Oatly Group AB is a holding company, which focuses on developing expertise around oats, a global power crop with inherent properties suited for sustainability and human health. It operates through the following geographical segments: Europe & International, North America and Greater China. The company was founded by Björn Öste in 1994 and is headquartered in Malmö, Sweden.

Oatly Group AB - ADR

Oatly Group

OTLY is trending as the community discusses potential catalysts, including a possible joint venture in China, and Mizuho's updated rating. Investors are closely watching for news that could positively impact the company's balance sheet and drive a turnaround, with some suggesting the stock is undervalued. Community members are debating the potential for a short squeeze and a shift in narrative to a lifestyle drink rather than just a milk alternative.

Verrica Pharmaceuticals, Inc. is a dermatology therapeutics company, which engages in identifying, developing, and commercializing pharmaceutical products for the treatment of skin diseases. Its products include Pipeline VP-102, Pipeline VP-103, and Pipeline VP-315. The company was founded by Matthew Davidson on July 3, 2013 and is headquartered in West Chester, PA.

Verrica Pharmaceuticals Inc

VRCA is trending following news of a $50 million private placement to retire debt and extend its cash runway into mid-2027, which investors see as a sign of financial stability. Community members are also highlighting recent insider buying, particularly a significant $17.5 million purchase by a director, fueling speculation of a potential short squeeze and increased confidence in the company's future. Biotech sector strength is adding to the positive momentum.

Pulse Biosciences, Inc. operates as an immuno-oncology company developing a proprietary oncolytic electroceutical therapy based on its Nano Pulse Stimulation (NPS) technology. It manufactures surgical and medical instruments using a novel and proprietary platform technology called Nano-Pulse Electro-Signaling. The NPES provides local tumor control and initiates an adaptive immune response with a vaccine-like effect by inducing immunogenic apoptosis of the cells. The company was founded on May 19, 2014 and is headquartered in Miami, FL.

Pulse Biosciences Inc

Pulse Biosciences is trending due to positive buzz around its cardiac surgical system and recent first-in-human data, signaling potential in atrial fibrillation treatment. The community is also discussing insider buying activity, contributing to investor interest. Comparisons to other trending tickers and positive sentiment around the technology's potential have further fueled the conversation.

Sigma bnb USD

BNB is trending as traders discuss its reaction to the 'blue box' support zone, with many anticipating a potential bounce. Community analysis focuses on Elliott Wave patterns, with some noting ETF developments and legal pressures impacting Binance Coin; despite this, the potential for a bullish move is still being discussed.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel nPulse technology using its proprietary Nanosecond Pulsed Field Ablation (nanosecond PFA or nsPFA) energy, today announced that...

Pulse Biosciences (NASDAQ:PLSE) Hits New 12-Month Low - Here's What Happened

Pulse Biosciences (NASDAQ:PLSE) Reaches New 12-Month Low - Time to Sell...

Pulse Biosciences is Now Oversold (PLSE)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a...

Pulse Biosciences (NASDAQ:PLSE) Posts Quarterly Earnings Results, Beats Estimates By $0.02 EPS

Pulse Biosciences (NASDAQ:PLSE - Get Free Report) announced its quarterly earnings data on Wednesday. The company reported ($0.29) earnings per share (EPS) for the quarter, beating analysts...

Pulse Biosciences, Inc. Announces Participation in Upcoming Investor Conferences

Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel nPulse technology using its proprietary Nanosecond Pulsed Field Ablation (nanosecond PFA or nsPFA) energy, today announced plans...

Pulse Biosciences, Inc (PLSE) Reports Q3 Loss, Lags Revenue Estimates

Pulse Biosciences (PLSE) delivered earnings and revenue surprises of +6.45% and -82.80%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Pulse Biosciences Announces First Enrollment in the NANOCLAMP AF Study

Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel nPulse technology using its proprietary Nanosecond Pulsed Field Ablation (nanosecond PFA or nsPFA) energy, today announced the...

Pulse Biosciences Schedules Third Quarter 2025 Business Updates and Financial Results Conference Call for November 5, 2025

Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel nPulse technology using its proprietary Nanosecond Pulsed Field Ablation (nanosecond PFA or nsPFA) energy, today announced it...

Pulse Biosciences Unveils Promising First-in-Human Data for nPulse

PLSE unveils strong first-in-human data for its nPulse Cardiac Surgical System, showcasing safety, speed, and durable AF treatment potential.

Current Price	$14.00
Prev Close	$13.33
Open	$13.34
Dividend Yield	0.00%
50-Day Moving Average	$16.69
Beta	1.23
Avg. Volume	160,837.96
PE Ratio	-12.15

52-Week High	$25.00
52-Week Low	$12.56
Market Capitalization	$934.51M
EPS (Annual)	-$0.9176
Price to Book	10.08
Revenue Per Employee	$0.00
Enterprise Value/EBITDA	N/A

PLSE
Pulse Biosciences Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest PLSE News

PLSEPulse Biosciences Inc